Company Monitoring Page for Biogen

latest headlines for company on cafepharma

CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington's intensifying drug-pricing push
Fierce Pharma
Thu, 09/16/21 - 10:50 am
Tags:
drug pricing, Medicare, Pharma CEOs, Eli Lilly, AbbVie, Bristol Myers Squibb, Biogen, GSK
Biogen leads the amyotrophic lateral sclerosis hopefuls
EP Vantage
Thu, 09/16/21 - 10:41 am
Tags:
ALS, Amylx, Biogen, Ionis Pharmaceuticals, AB Science, Cytokinetics
Biogen admits Aduhelm launch ‘slower than we anticipated’
Stat
Thu, 09/9/21 - 11:16 am
Tags:
Biogen, Aduhelm, drug launches, Alzheimer's disease
First Biogen, now the FDA: Congressional Democrats request agency records over Aduhelm's approval
Fierce Pharma
Thu, 09/2/21 - 10:10 pm
Tags:
Biogen, FDA, Janet Woodcock, Aduhelm
Biogen's Aduhelm label far exceeds clinical trial population, study says. That could bring real-world surprises
Fierce Pharma
Wed, 09/1/21 - 10:48 pm
Tags:
Biogen, Aduhelm, clinical trials, Alzheimer's disease
Biogen providing Aduhelm for free while waiting for Medicare coverage decision
Beckers Hospital Review
Tue, 08/31/21 - 10:02 pm
Tags:
Biogen, Aduhelm, Medicare, Alzheimer's disease
The sellside’s most controversial products
EP Vantage
Tue, 08/31/21 - 10:54 am
Tags:
Merck, Keytruda, Biogen, Aduhelm, Pfizer, Vir Biotechnology
Reimbursement begins slowly for Biogen’s expensive Alzheimer’s drug
Endpoints
Mon, 08/30/21 - 11:04 am
Tags:
Medicare, Biogen, Aduhelm, reimbursement, Alzheimer's disease
Could Biogen Acquire Axsome Therapeutics?
Motley Fool
Fri, 08/20/21 - 10:56 am
Tags:
Biogen, Axsome Therapeutics, M&A
Biogen's controversial Alzheimer's med Aduhelm turned away by VA on efficacy and safety worries
Fierce Pharma
Thu, 08/12/21 - 12:05 am
Tags:
Biogen, Aduhelm, Alzheimer's disease, Veteran's Affairs
Federal watchdog will review the controversial FDA approval of Biogen’s Alzheimer’s drug
Stat
Wed, 08/4/21 - 10:44 pm
Tags:
Biogen, Aduhelm, FDA, drug approvals, Alzheimer's disease
Biogen, Eisai are pushing for another accelerated Alzheimer's OK — this time for BAN2401
Endpoints
Wed, 08/4/21 - 10:55 am
Tags:
Biogen, Eisai, FDA, Alzheimer's disease, BAN2401
Alzheimer’s patients are in limbo as hospitals, insurers grapple with whether to offer Aduhelm
Stat
Wed, 08/4/21 - 10:48 am
Tags:
Alzheimer's disease, patients, Aduhelm, Biogen
‘Some way to go’ before decision on Biogen Alzheimer’s drug, says UnitedHealth
Biopharma Reporter
Tue, 08/3/21 - 11:46 pm
Tags:
Unitedhealth Group, Biogen, Aduhelm, payers, Alzheimer's disease
Rare disease drugmakers to Congress: Don't gut the accelerated approval pathway
Endpoints
Tue, 08/3/21 - 11:02 am
Tags:
FDA, Rick Pazdur, accelerated approvals, Biogen, Aduhelm, US Congress
How well will Biogen's Alzheimer's drug Aduhelm perform in the real world? This study is set to find out
Fierce Pharma
Thu, 07/29/21 - 11:03 pm
Tags:
Biogen, Aduhelm, Alzheimer's disease, RWE, real world evidence, real world data
JAMA Paper Withdrawal Adds One More Layer to Aduhelm Controversy
BioSpace
Wed, 07/28/21 - 11:15 pm
Tags:
Biogen, Aduhelm, Alzheimer's disease, JAMA
Biogen pushes for broad CMS coverage of Alzheimer's drug — while Eli Lilly looks to escape an NCD
Endpoints
Wed, 07/28/21 - 10:22 am
Tags:
CMS, Biogen, Aduhelm, Alzheimer's disease, Eli Lilly, donanemab
Biogen, Ionis tout data from early study of RNA-based Alzheimer's drug
BioPharma Dive
Tue, 07/27/21 - 04:31 pm
Tags:
Biogen, Ionis Pharmaceuticals, Alzheimer's disease, BIIB080
Panel of neuroscience experts lays out the complications with using Biogen's new Alzheimer's drug
Endpoints
Tue, 07/27/21 - 10:42 am
Tags:
Biogen, Aduhelm, Alzheimer's disease

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.